A clinical trial to investigate the triple combination of GLPG-2451, GLPG-2222 and GLPG-2737

Trial Profile

A clinical trial to investigate the triple combination of GLPG-2451, GLPG-2222 and GLPG-2737

Planning
Phase of Trial: Phase II

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs GLPG 2222 (Primary) ; GLPG 2451 (Primary) ; GLPG 2737 (Primary)
  • Indications Cystic fibrosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jun 2017 New trial record
    • 20 Jun 2017 According to a Galapagos media release, this trial is expected to begin in Q4 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top